Drugmaker Lupin said on Wednesday it had received preliminary approval from US health regulators to sell Ivacaftor tablets for cystic fibrosis in the US. In...
On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....
As omicron and its sub-variants continue to spread globally, there may be some benefit to delivering a second dose of a coronavirus booster vaccine to...
Sun Pharmaceutical Industries Ltd today made a press release, today, in order to clarify the ongoing corporate governance issue. Sun Pharma explained that the loan...
Wockhardt Ltd. announced that the drugmaker has received approval from the U.S. health regulator, USFDA, for the generic version of Gleevec used for the treatment...
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...
Zydus Cadila has announced that the US health regulator has given final approval to market generic Abacavir and Lamivudine tablets, which are primarily used for...
Morepen Laboratories has received approval for its Baddi facility at Himachal Pradesh, from USFDA. The company’s Baddi facility has received approval for the manufacture of bulk drug Atorvastatin...